CA
SIOX

Cliff Asness’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Cliff Asness’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,195
Closed -$94K – 2349
2018
Q2 		$94K Sell
5,195
-11,793
-69% -$174K ﹤0.01% 2293
2018
Q1 		$181K Sell
16,988
-2,263
-12% -$36.4K ﹤0.01% 2159
2017
Q4 		$812K Sell
19,251
-1,486
-7% -$66.7K ﹤0.01% 1745
2017
Q3 		$1.14M Buy
20,737
+14,552
+235% +$2.45M ﹤0.01% 1621
2017
Q2 		$1.15M Buy
+6,185
New +$1.08M ﹤0.01% 1622
2017
Q1 		– Sell
-1,399
Closed -$139K – 2270
2016
Q4 		$139K Buy
+1,399
New +$147K ﹤0.01% 2191

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Cliff Asness's SIOX Position: Q3 2018 in Review

Cliff Asness sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2018, closing a stake of 5,195 shares — an estimated $94K sold.

Cliff Asness first reported a position in SIOX in Q4 2016 and held it in 6 quarters. The position peaked at $1.15M in Q2 2017. 61 funds tracked by Wall St. Rank hold SIOX as of Q3 2018.

  • Cliff Asness reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Cliff Asness sold 5,195 Sio Gene Therapies Inc. Common Stock shares in Q3 2018, an estimated $94K.
  • Cliff Asness first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 6 quarters.
  • Cliff Asness's Sio Gene Therapies Inc. Common Stock position peaked at $1.15M in Q2 2017.
  • 61 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2018.

Based on AQR Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.